Mod­er­na dis­putes NIH claims on Covid-19 vac­cine patents, says it of­fered to make gov­ern­ment co-own­ers

4 years ago
Coronavirus

As $2B 'su­per­plan­t' moves ahead, Sam­sung Bi­o­log­ics touts plans for fifth fa­cil­i­ty at South Ko­re­an site

4 years ago
Manufacturing

Fu­ji­film boosts man­u­fac­tur­ing ca­pac­i­ty along­side R&D; Bax­ter In­ter­na­tion­al will in­vest $100M in Bio­Phar­ma So­lu­tions

4 years ago
Manufacturing

Covid-19 roundup: Mod­er­na notes high­er my­ocardi­tis risk for young males when com­pared to Pfiz­er's vac­cine; EMA signs ...

4 years ago
Coronavirus

Kaléo to pay out more than $12M in false claims case re­gard­ing high-priced ver­sion of cheap opi­oid over­dose ...

4 years ago
News Briefing

List Bio to join In­di­ana biotech com­mu­ni­ty with $125M CMO in­vest­ment, 210 new hires

4 years ago
Manufacturing

Scoop: Famed can­cer re­searcher — and biotech founder — Lew Cant­ley is head­ed to Dana-Far­ber

4 years ago
R&D

Too much iron? Phar­ma­cos­mos is bet­ting $225M on a new po­ten­tial so­lu­tion for that

4 years ago
Deals

Acrivon bags a megaround to ad­vance an old Eli Lil­ly pro­gram, 5 months af­ter launch. Is an IPO far be­hind?

4 years ago
Financing

Bono in­vests in biotech? Pep­tide play­er is head­ed to the US — with celebri­ty in­vestors back­ing its move

4 years ago
People
Financing

In­fer­til­i­ty and alien ba­bies? Klick Health part­ners with YouTube to tack­le most searched Covid vac­cine con­cerns

4 years ago
Pharma
Marketing

Genen­ta is at­tempt­ing a rare biotech leap from Mi­lan to Wall Street

4 years ago
Financing

Roche, AC Im­mune at­tempt to flesh out an­ti-tau Alzheimer's da­ta, but the fore­cast re­mains cloudy

4 years ago
R&D

NIH 'not done' fight­ing Mod­er­na over Covid vac­cine patents, di­rec­tor Fran­cis Collins says

4 years ago
Coronavirus

Months af­ter a Mer­ck spin­out, Organon con­tin­ues its string of deals with a $954M buy­out pack­age

4 years ago
Deals
R&D

A bet­ter way to con­trol where drugs go? In­vestors bet on small biotech's mis­sion to 'click' to­geth­er can­cer meds

4 years ago
Financing

FDA+ roundup: More than 2 years af­ter a CRL, Lex­i­con is still bat­tling the de­ci­sion; UK phar­ma in­dus­try weighs ...

4 years ago
FDA+

Wel­come to CPhI week: The drug man­u­fac­tur­ing in­dus­try's pre­mier con­fer­ence kicks off with the winds of change blow­ing

4 years ago
Outsourcing
Manufacturing

CPhI: The time of the CMO is up­on us as mas­sive in­dus­try growth dri­ves surge in out­sourc­ing ca­pac­i­ty

4 years ago
Outsourcing
Manufacturing

CPhI: Biotech's au­toma­tion boom is on­ly just be­gin­ning amid huge surge in de­mand due to Covid-19

4 years ago
Manufacturing

CPhI: In­dus­try ex­ecs ready to put a dif­fi­cult cou­ple years be­hind them as phar­ma con­fi­dence looks bull­ish

4 years ago
Manufacturing

CPhI: As pan­dem­ic reach­es its fi­nal stages, an in­dus­try busier than ever re­flects on lessons learned

4 years ago
Outsourcing
Manufacturing

CPhI: As Covid-19 re­stric­tions ease, an in­spec­tion back­log could have a big ef­fect on new drugs, gener­ics

4 years ago
Manufacturing

CPhI: Reg­u­la­to­ry changes have led to a CMO boom in Chi­na, but can that con­tin­ue?

4 years ago
Manufacturing
First page Previous page 615616617618619620621 Next page Last page
A service from the Financial Times